Results 241 to 250 of about 288,381 (292)
Topical Imiquimod for Oral Cavity Leukoplakia and Dysplasia: A Scoping Review
Otolaryngology–Head and Neck Surgery, EarlyView.Abstract Objective Imiquimod, a toll‐like receptor 7 agonist, is currently FDA‐approved for treatment of actinic keratoses, superficial BCC, and external genital warts. It has also demonstrated promise in off‐label use in the treatment of oral cavity leukoplakia and dysplasia.
Megan K. Scharner +3 more
wiley +1 more source
Pseudovirus-Based Systems for Screening Natural Antiviral Agents: A Comprehensive Review. [PDF]
Int J Mol SciTrischitta P +3 more
europepmc +1 more source
A Comparison of Active Pharmacovigilance Strategies Used to Monitor Adverse Events to Antiviral Agents: A Systematic Review. [PDF]
Drug SafFerreira-da-Silva R +7 more
europepmc +1 more source
Five-Year Prospective Follow-Up of Patients with Hepatitis C Virus Infection Treated with Direct-Acting Antiviral Agents. [PDF]
Infect Drug ResistZhang Y +5 more
europepmc +1 more source
Direct-Acting Antiviral Agents in Prevention of Maternal-Fetal Transmission of Hepatitis C Virus in Pregnancy. [PDF]
PathogensHartley C, Van T, Karnsakul W.
europepmc +1 more source
Viral Factors in Modulation of Host Immune Response: A Route to Novel Antiviral Agents and New Therapeutic Approaches. [PDF]
Int J Mol SciTarasova O +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Dermatologic Clinics, 2001
The potential severity of many viral infections and the lack of appropriate treatment for these diseases have been a source of endless frustration and helplessness for clinicians. The newly developed field of antiviral therapy is expanding at an astounding rate, with new discoveries each day.
T J, Brown +2 more
openaire +3 more sources
The potential severity of many viral infections and the lack of appropriate treatment for these diseases have been a source of endless frustration and helplessness for clinicians. The newly developed field of antiviral therapy is expanding at an astounding rate, with new discoveries each day.
T J, Brown +2 more
openaire +3 more sources
2021
Nowadays, many viral infections have emerged and are taking a huge toll on human lives globally. Meanwhile, viral resistance to current drugs has drastically increased. Hence, there is a pressing need to design potent broad-spectrum antiviral agents to treat a variety of viral infections and overcome viral resistance.
Sako, Mirzaie +4 more
openaire +2 more sources
Nowadays, many viral infections have emerged and are taking a huge toll on human lives globally. Meanwhile, viral resistance to current drugs has drastically increased. Hence, there is a pressing need to design potent broad-spectrum antiviral agents to treat a variety of viral infections and overcome viral resistance.
Sako, Mirzaie +4 more
openaire +2 more sources
Mayo Clinic Proceedings, 1987
Amantadine is well established as the preferred antiviral agent for the prophylaxis of influenza A and may also be beneficial therapeutically when used early in the course of the disease. Idoxuridine is applicable only in the treatment of herpetic keratitis.
P E, Hermans, F R, Cockerill
openaire +3 more sources
Amantadine is well established as the preferred antiviral agent for the prophylaxis of influenza A and may also be beneficial therapeutically when used early in the course of the disease. Idoxuridine is applicable only in the treatment of herpetic keratitis.
P E, Hermans, F R, Cockerill
openaire +3 more sources